Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Irinotecan for Malignant Ascites
NCT07397819Phase 2Recruiting
- Start
- Nov 2025
- Primary completion
- Jun 2028
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nanoliposomal irinotecan in malignant ascites. Started Nov 2025; status: recruiting.
02
Drugs
nanoliposomal irinotecan
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT07397819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397819.